K. McCollister

Cost-Effectiveness of BuprenorphineNaloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse

E. Nunes, Xuan Yang, B. Schackman, 2018, Annals of Internal Medicine.

The cost of crime to society: new crime-specific estimates for policy and program evaluation.

Michael T French, M. French, K. McCollister, 2010, Drug and alcohol dependence.

Criminal justice measures for economic data harmonization in substance use disorder research

R. Kronmal, Xuan Yang, W. Cunningham, 2018, Health & Justice.

Economic evaluation of drug court: methodology, results, and policy implications

M. French, C. Leukefeld, K. McCollister, 2004 .

Secondhand Smoke Exposure and Depressive Symptoms

David J Lee, A. Caban-Martinez, L. Fleming, 2010, Psychosomatic medicine.

How simulation modeling can support the public health response to the opioid crisis in North America: Setting priorities and assessing value.

Brandon D. L. Marshall, G. Zarkin, J. Chhatwal, 2020, The International journal on drug policy.

The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices

Timothy R. Huerta, Darcy A. Freedman, Charles E. Knott, 2020, Drug and Alcohol Dependence.

The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings.

M. French, K. McCollister, K. Mccollister, 2003, Addiction.

Sustained low influenza vaccination rates in US healthcare workers.

David J Lee, A. Caban-Martinez, L. Fleming, 2010, Preventive medicine.

Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review.

B. Schackman, D. Polsky, Sean M. Murphy, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.